| scholarly article | Q13442814 |
| P2093 | author name string | Carlo V Catapano | |
| Davide Genini | |||
| P2860 | cites work | Prostacyclin-dependent apoptosis mediated by PPAR delta | Q24291677 |
| The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells | Q24314509 | ||
| The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling | Q24530668 | ||
| PPAR delta: a dagger in the heart of the metabolic syndrome | Q24541527 | ||
| Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis | Q24541529 | ||
| Critical roles of PPAR beta/delta in keratinocyte response to inflammation | Q24599297 | ||
| Proteolytic processing and assembly of the C5 subunit into the proteasome complex | Q28145524 | ||
| Transcriptional repression of atherogenic inflammation: modulation by PPARdelta | Q28206569 | ||
| Back to the future with ubiquitin | Q28240711 | ||
| A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors | Q28246411 | ||
| A genomic and functional inventory of deubiquitinating enzymes | Q28284911 | ||
| PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs | Q28343682 | ||
| Peroxisome proliferator-activated receptors: nuclear control of metabolism | Q28374684 | ||
| Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta | Q28505497 | ||
| Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth | Q28590099 | ||
| Nuclear receptors and lipid physiology: opening the X-files | Q29619362 | ||
| PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine | Q33207854 | ||
| Ubiquitin-mediated proteolysis: biological regulation via destruction | Q33910576 | ||
| Roles of PPARs in health and disease. | Q33934899 | ||
| Emerging roles of ubiquitin in transcription regulation | Q34129014 | ||
| Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. | Q34157973 | ||
| Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis | Q34415552 | ||
| Involvement of PPAR nuclear receptors in tissue injury and wound repair | Q34416422 | ||
| PPAR gamma and human metabolic disease | Q34416432 | ||
| Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells | Q34478047 | ||
| Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma | Q34786102 | ||
| How the ubiquitin-proteasome system controls transcription | Q35075758 | ||
| Peroxisome-proliferator-activated receptors and cancers: complex stories | Q35621403 | ||
| Dynamic combinatorial networks in nuclear receptor-mediated transcription | Q36217187 | ||
| Combinatorial roles of nuclear receptors in inflammation and immunity | Q36403404 | ||
| Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer | Q37290958 | ||
| Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. | Q40429907 | ||
| Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. | Q40559153 | ||
| Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins | Q42484044 | ||
| Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation | Q42803719 | ||
| Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma | Q43757113 | ||
| Stabilization of peroxisome proliferator-activated receptor alpha by the ligand | Q43762158 | ||
| Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes | Q44064081 | ||
| Different ways to regulate the PPARalpha stability. | Q44922220 | ||
| Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. | Q47868953 | ||
| Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. | Q53347326 | ||
| PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. | Q53921636 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein ubiquitination | Q3547638 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 11776-11785 | |
| P577 | publication date | 2007-02-26 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Block of nuclear receptor ubiquitination. A mechanism of ligand-dependent control of peroxisome proliferator-activated receptor delta activity | |
| P478 | volume | 282 |
| Q53684513 | An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors. |
| Q40084685 | Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta |
| Q35569436 | Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function |
| Q33642453 | Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1. |
| Q35920226 | MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet |
| Q37190455 | Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis |
| Q37360041 | PPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal. |
| Q41677812 | PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments |
| Q27437643 | PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesis |
| Q39017204 | PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells |
| Q41144730 | Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer |
| Q36023224 | Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells. |
| Q42183885 | Regulation of peroxisome proliferator-activated receptors by e6-associated protein |
| Q42367857 | SPA70 is a potent antagonist of human pregnane X receptor. |
| Q92709736 | Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors |
| Q34995169 | The G32E functional variant reduces activity of PPARD by nuclear export and post-translational modification in pigs |
| Q39876254 | The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells |
| Q35964903 | The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. |
| Q37103852 | The therapeutic potential of the proteasome in leukaemia |
| Q33585657 | Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications |
| Q31103456 | Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer |
| Q90644328 | Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis |
Search more.